We have a solution for everything – and the corresponding experience. In our current seven areas of expertise, we are at your disposal with our comprehensive know-how.

All Solutions

Please, come in!

24/7 available for you: In our virtual showroom, we present our extensive portfolio and latest innovations. 



We are specialists for complete handling systems for pharmaceutical and medical products. Our solutions are decisive in the field of contactless and safe transport of e.g. glass syringes.

Overview Handling



As the world's leading inspection expert, we develop solutions for the pharmaceutical and biotech industries. Our range of products extends from high-performance machines and semi-automatic machines to laboratory units and inspection applications for in-process control.

Overview Inspection

Machine finder

Packaging materials

Packaging materials

As long-standing specialists, we develop packaging solutions for innovative and high-quality secondary pharmaceutical packaging made of cardboard. We offer you solutions for counterfeit protection, standard folding boxes and much more.

Overview Packaging materials


You need help with a specific product or have questions about one of our areas of expertise? Take advantage of our extensive range of services, we will support you quickly and easily.

All Services



We offer our customers a wide range of inspection solutions and quality controls at the highest level. Learn more about the right technology for your requirements.

Overview Inspection services

Packaging machines

Packaging machines

Our packaging machines ensure maximum flexibility and productivity for your packaging processes. Learn more about our modular, customer-specific packaging solutions.

Overview Packaging machines Services

Packaging materials

Packaging materials

The demands on pharmaceutical packaging are high: it should be forgery-proof and childproof, but also compact and sustainable. Find out here how we make packaging future-proof.

Overview Packaging materials Services

About us

We at Körber in the Pharmaceuticals business area are the people to contact when it comes to pharmaceutical products. As a leading system provider, we advise our customers from the development and production to the inspection and packaging of their products.

All about us


Media center

In our Mediacenter you will find all content related to our webinars, product and brand information such as downloads, videos and the Virtual Showroom collected in one place.

To our media center



Would you like to know how we have solved different customer requirements sustainably and efficiently? 
What project partners say about us or which industry awards our innovations have received? 


Remaining flexible: Pay-per-use leasing of machines

What has become common concerning carsharing and streaming in people’s private lives has now also been introduced into the pharmaceutical and biotech sectors by Körber: With its pay-per-use service, Körber offers pharmaceutical and biotech customers an innovative financing solution that enables companies to lease machines instead of buying them. Moreover, they only pay for the actual use of the machines. This gives companies a new degree of flexibility, as exemplified by a European pharmaceutical manufacturer.

The financing model is currently especially in demand for Track & Trace solutions. Companies can lease machines instead of buying them and pay only for their use.

As digitization spreads, the pay-per-use concept has long become part of our everyday life. As a result, carsharing apps are used to rent vehicles at short notice, a touch ID on a smartphone is all it takes to rent an e-bike, and movies and music can be streamed almost everywhere. Instead of having to buy their own cars, e-bikes, or blue-ray discs, customers only purchase the right to use products or services for a certain amount of time without having to buy the product itself.

The Business Area Pharma of the international technology group Körber has adapted this concept for a use-based financing service. It is one of the first suppliers of machines and facilities for the pharmaceutical sector to do so. The innovative financing model helps companies improve their liquidity because they no longer have to buy machines. They lease them instead and only have to pay for their use in line with their actual production volume. “At our Business Area, this financing model is currently especially in demand for Track & Trace solutions. However, the pay-per-use service is available for almost any machine from our entire portfolio,” says Christian Frenz, Area Sales Manager at Körber. It makes companies extremely flexible. In addition, it opens up new possibilities for machine procurement and creates more room for making other investments.

Best practice: Pay-per-use service solves customer problem

The advantages of the pay-per-use service are demonstrated, for example, by a European pharmaceutical manufacturer who was already using this financing model in 2018. A change in the law forced the customer to quickly add a system for legally compliant serialization to the packaging line at one of its locations. However, the company hadn’t planned a budget for the corresponding machine in that fiscal year. In order to continue with production, the company would have needed to transport the packaged products from the manufacturing facility to another location so that they could be coded there. It would have been a logistical nightmare! The customer turned to Körber and discovered the latter’s pay-per-use service to be the ideal solution.

The Track & Trace experts from the Business Area Pharma developed a flexible leasing solution for the machine that the customer required. This enabled the customer to avoid paying the high initial costs and the associated difficulties in the planning of its budget. The required machine, an ItemUnit-TE Basic, was installed at the customer’s location only a few weeks later. The customer was able to assure the production line’s continued operation, thanks to the modular system for the serialization, verification, and labeling of individual pharmaceutical sales units with a tamper-evident seal.

lPay-per-use customers don’t pay until the machine begins production and thus contributes to their value-added.r

Raphael Just, Business Development Manager at the Körber Business Area Pharma

The pay-per-use service not only makes the procurement of a machine simple and transparent, but also the invoicing of the leasing payments.

The price per unit produced drops at higher capacity utilization

The pay-per-use service not only makes the procurement of a machine simple and transparent, but also the invoicing of the leasing payments. The payments are made at fixed times (e.g. annually) and are based on the number of units that the leased machine has produced. “In line with the expression ‘pay per use’, the customer only pays for the actual use of the machine,” explains Frenz. This results in several benefits for companies: Unlike the case with conventional machine purchases, there are no high initial costs. Moreover, in many cases capital does not have to be tied up for the long term in fixed assets, provided the customer’s balance sheet permit this. “Instead, pay-per-use customers don’t pay until the machine begins production and thus contributes to their value-added,” says Raphael Just, Business Development Manager at Körber. This also means that the price per unit produced drops as capacity utilization increases.

lWith our pay-per-use model, the customer only pays for the actual use of the machine.r

Christian Frenz, Area Sales Manager at the Körber Business Area Pharma

In addition, the leasing payments enable the cost of a machine to be spread over several years. If the amounts produced by the machine decline during this period, the leasing payments correspondingly decrease as well. And there are additional benefits for pay-per-use customers. The machine leasing offer includes a host of services. Experts from Körber help the customers launch production, provide on-site training for their employees, and take care of the maintenance and spare part procurement of all of the pay-per-use machines. “As a partner, we thus share the risks and opportunities with our customers,” says Just.

The term of the financing model can be agreed individually. Once the contract expires, leasing customers can decide whether they would like to buy the machine at its residual value or return it to Körber.

Maximum flexibility even during the term of the contract The average term of a pay-per-use leasing contract is around five years. It can adapt to individual needs. Once the contract expires, leasing customers can decide whether they would like to buy the machine at its residual value or return it to Körber. Companies can also buy the machine during the contract term and thus make it their property.

“This means that companies don’t have to make a final decision when they conclude a leasing agreement. They can respond to developments as needed throughout the entire term of the contract,” says Just. In a market environment that is characterized by complex manufacturing processes, declining numbers of units, and customized products, the pay-per-use service greatly reduces the risks customers face when they acquire a new machine. The use-based model keeps the leasing costs manageable and also enables them to be incorporated into the current annual budgets. In this way, Körber provides pharmaceutical companies with an alternative to the usual purchase of machines and has more flexibility to meet the sector’s current and future challenges.

Any questions?

Would you like to learn more about the pay-per-use service and our leasing machines?

Please get in touch with us!

Körber – delivering the difference in pharma


No comments

Write comment

* These fields are required

Back to top
Back to top